Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Tohoku Univ. to Start Clinical Trial for ALS Drug in Japan
July 25, 2011
- Over 11,000 Users Now Registered at Daiichi Sankyo's “Handheld Mother-Child Notebook”Website
July 25, 2011
- Medium-sized Domestic Drugmakers to Accelerate M&As, Entry into Overseas Market: Alan Thomas of IMS Japan
July 25, 2011
- Everolimus Recommended for SEGA by CHMP: Novartis
July 25, 2011
- Sanofi Ties Up with Rib-X for Research of Novel Antibiotics
July 25, 2011
- Over 30% of Schizophrenia Patients Prescribed 3 or More Drugs: Survey
July 25, 2011
- Of 4 Major Drug Wholesalers, Only Medipal to Increase Operating Profits in FY2011: Mizuho
July 25, 2011
- FDA Accepts Application for Dacogen for AML: Eisai
July 25, 2011
- Lyrica Shows Efficacy for Fibromyalgia in PIII in Japan: Pfizer
July 25, 2011
- NBI Expects Surge in Sales of Prazaxa after Lifting of Ban on Long-term Prescription
July 25, 2011
- Shionogi Licenses IPF Treatment Pirfenidone to Ildong of South Korea
July 25, 2011
- EPPV Finds No Safety-related Problems with Rasuritek: sanofi-aventis
July 25, 2011
- Lantus Plus One Mealtime Dose of Apidra Non-inferior to Insulin Aspart: Sanofi
July 25, 2011
- Eisai Obtains Marketing Rights to 2 Drugs from Orion in China
July 25, 2011
- Aricept Generics Approved from 33 Companies
July 25, 2011
- Novo Nordisk's Ultra-Long-Acting Insulin Reduces Incidence of Hypoglycemia
July 25, 2011
- Astellas to Market Pfizer's Caduet from October
July 25, 2011
- DSP to Launch Aricept Generics to Expand Product Lineup in CNS Field
July 25, 2011
- 4,000 Patients Registered with All-Case Survey on Orencia: Bristol-Myers
July 25, 2011
- Astellas Files Suit Against Sandoz Canada Over Generic Version of Prograf
July 25, 2011
ページ
As many as 47 new drug candidates are expected to win approval or secure NHI price listing in Japan in…
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…